Kevin Kunzmann

A perspective on what's moved virtually, and what hasn't, since the pandemic began in March.

An interview with a Cleveland Clinic investigator on adjusting macular edema screening methods.

Interim findings from a cross-sectional study shows a correlation between worse cognitive scoring and a greater rate of intravitreal injections.

A new analysis of a trio of intravitreal agents show maintained visual acuity in treatment-naive patients for at least 5 years.

The specialty is on the precipice of advancement. What gets it over the hurdle?

New research suggests IVC filter placement could attenuate the risk of pulmonary embolism in patients with cancer-related DVT.

A look at how the specialty functions in telemedicine, and how it could work better with primary care physicians and endocrinologists.

How the condition affects both the vision and mindset of patients, and what clinical outcomes for anti-VEGF research do to address it.

New phase 1/2 data shows AAV-RGPR may benefit a previously untreated population of inherited retina disease boys and young men.

A look at how primary care patients begin to present with diabetic retinopathy risk.

New PANORAMA findings could give ophthalmologists confidence in longer time between administrations after year 2.

New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.

How a decades-long issue has resulted in at-need patients lacking confident, available physicians.

An expert explains why little progress has been made in disease prevalence and burden in the US.

The vaccine induced T cell response in about 2 weeks, and antibody response in about 4 weeks, among 1000-plus healthy adults.

A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.

The first prospective safety trial using oral factor Xa inhibitor in patients undergoing laparotomy shows women preferred and adhered to the drug.

The COVID-19 vaccine candidate, mRNA-1273, induced immune responses in all 45 of its volunteer patients administered doses.

The practice of genetic testing has been useful in clinically addressing found cases of familial hypercholesterolemia, among other conditions, but no clinical practice guidelines currently exist for testing patients with suspected hereditary dyslipidemia.

What does personalized outpatient care look like for a cardiology institute during the pandemic?

A study shows surveyed patients were nearly twice as likely to be satisfied with the care they receive from a usual clinician than an emergency caregiver.

A streamlined testing procedure in sub-Saharan Africa shows improved infant and newborn patient identification.

A majority of those who fall under the criteria for recommended HIV testing has not once received such testing.

Genomics, in combination with patient demographic risks, could help better inform clinicians of persons at risk for worsened chronic pulmonary burden.

A noninferiority study showed parents were not more anxious when their discharged child was treated as-need—nor was their child at greater health risk.

New research shows patients with both conditions have greater levels of particular cytokines and metabolic proteins.

A look at the risks patients face due to the pandemic—and what minority patients may face daily.

A look at the quarter of available drugs for the rare disease, and how they fare in relation to evolving understanding of disease effect.

ADHD, autism spectrum disorder, seizures, and even developmental delays are asssociated with a two-fold risk of asthma in US children.

Where do investigators go next with the 8000-plus COPD patient research?